1475 related articles for article (PubMed ID: 16627016)
1. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
6. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
Bredenoord AJ; Hemmink GJ; Smout AJ
Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus.
Zentilin P; Conio M; Mele MR; Mansi C; Pandolfo N; Dulbecco P; Gambaro C; Tessieri L; Iiritano E; Bilardi C; Biagini R; Vigneri S; Savarino V
Aliment Pharmacol Ther; 2002 May; 16(5):893-8. PubMed ID: 11966497
[TBL] [Abstract][Full Text] [Related]
8. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
[TBL] [Abstract][Full Text] [Related]
9. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
10. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
[TBL] [Abstract][Full Text] [Related]
11. Barrett's oesophagus: a clinical study of 52 patients.
Cooper BT; Barbezat GO
Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
Frazzoni M; De Micheli E; Zentilin P; Savarino V
Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174
[TBL] [Abstract][Full Text] [Related]
13. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
14. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
15. The role of the hiatus hernia in gastro-oesophageal reflux disease.
Gordon C; Kang JY; Neild PJ; Maxwell JD
Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832
[TBL] [Abstract][Full Text] [Related]
16. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
Willich SN; Nocon M; Kulig M; Jaspersen D; Labenz J; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P
Aliment Pharmacol Ther; 2006 Feb; 23(3):371-6. PubMed ID: 16422996
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R
Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis.
McDougall NI; Johnston BT; Collins JS; McFarland RJ; Love AH
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1161-7. PubMed ID: 9471021
[TBL] [Abstract][Full Text] [Related]
19. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
20. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
